Australian biopharmaceutical company Propanc Biopharma has announced a significant strategic move, securing up to $100 million from a crypto-focused family office, Hexstone Capital. This funding will establish a crypto treasury aimed at accelerating the development of its lead cancer therapy, PRP, which is slated for human trials in late 2026. The company views this as a transformative step to strengthen its financial position and advance its oncology platform.
Key Takeaways
-
Propanc Biopharma plans to create a $100 million crypto treasury.
-
Funding comes from Hexstone Capital, a crypto-focused family office.
-
Proceeds will support the development of Propanc's cancer therapy, PRP.
-
PRP is expected to enter human trials in the second half of 2026.
-
The move aims to strengthen Propanc's balance sheet and advance its oncology platform.
Strategic Financial Initiative
Propanc Biopharma has entered into a private placement agreement with Hexstone Capital, structured through convertible preferred stock. This agreement provides an initial investment of $1 million, with the potential for up to $99 million in follow-on funding over the next twelve months. The primary objective of establishing the crypto treasury is to bolster the company's financial resources and expedite the progress of its proenzyme-based oncology platform.
Advancing Cancer Therapy Development
The funds generated from the crypto treasury will be instrumental in accelerating the development of Propanc's lead cancer therapy, PRP. This therapy is designed to target not only metastatic cancer from solid tumors but also potentially various chronic diseases, leveraging the mechanism of action of proenzyme therapy. The company is targeting the second half of 2026 for the commencement of first-in-human trials for PRP.
Broader Industry Trend
Propanc is not alone in exploring cryptocurrency strategies. Other biotech firms, such as Sonnet BioTherapeutics and Sharps Technology, have also turned to crypto to potentially reignite investor interest. While the specific digital assets Propanc intends to acquire for its treasury have not been disclosed, Hexstone Capital's clients have a diverse investment portfolio that includes major cryptocurrencies like Bitcoin (BTC) and Ether (ETH), as well as other altcoins.
Market Reaction and Challenges
Despite the strategic announcement, Propanc's stock (PPCB) experienced a decline of 10.5% on the Nasdaq following the news. This reaction highlights the volatility and mixed reception that crypto treasury strategies can face. In recent months, companies holding Bitcoin treasuries have seen significant fluctuations in their market capitalization, with some even needing to divest holdings to manage debt obligations.
Sources
This article was created with support from AI-driven technology, drawing on multiple reputable sources. The final content has been thoroughly reviewed and edited by BlockzHub's editorial team to ensure accuracy, clarity, and coherence. Original reporting sources are credited whenever appropriate and as required. The opinions expressed in this article do not necessarily represent the official views or positions of BlockzHub. This article is intended for informational purposes only and should not be considered financial or professional advice. Investing involves risk, and you should consult a qualified financial advisor before making any investment decisions.